ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintSite TitleTitle ChevronIcon Twitter
Health Technology

Sysmex Corp.

Business Summary

Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. It operates through the following geographical segments: Japan, Americas, Europe, Middle East, and Africa (EMEA), China, and Asia Pacific. The company was founded by Taro Nakatani on February 20, 1968 and is headquartered in Kobe, Japan.

Financial Highlights

Mar 2020 JPYUSD
Revenue301,980M2,777.44M
Gross Profit159,807M1,469.81M
Operating income54,501M501.27M
Income before tax49,433M454.65M
Net income34,882M320.82M
EBITDA78,456M721.59M
Diluted EPS166.921.53
Dividends Per Share720.66
Total Assets389,291M3,606.04M
Total liabilities110,941M1,027.65M
Total equity277,684M2,572.21M
Operating cash flow53,182M489.13M
Currency in JPYCurrency in USD

Historical Data

 Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Revenue 252,622M 249,899M 281,935M 293,506M 301,980M
Gross Profit 150,690M 141,777M 158,949M 161,607M 159,807M
Operating income 60,710M 50,822M 59,947M 60,799M 54,501M
Income before tax 57,809M 48,946M 58,117M 57,955M 49,433M
Net income 39,278M 40,635M 39,221M 41,224M 34,882M
EBITDA 72,820M 63,203M 74,590M 76,641M 78,456M
Diluted EPS 188.30 194.74 187.84 197.28 166.92
Dividends Per Share 52 58 66 70 72
Total Assets 263,917M 279,817M 321,979M 346,775M 389,291M
Total liabilities 82,864M 71,248M 80,531M 81,588M 110,941M
Total equity 182,801M 209,407M 240,750M 264,449M 277,684M
Operating cash flow 41,794M 32,832M 52,240M 44,743M 53,182M
 Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Revenue 2,103.70M 2,307.73M 2,543.79M 2,646.70M 2,777.44M
Gross Profit 1,254.86M 1,309.26M 1,434.13M 1,457.30M 1,469.81M
Operating income 505.56M 469.32M 540.87M 548.25M 501.27M
Income before tax 481.40M 452.00M 524.36M 522.61M 454.65M
Net income 327.08M 375.25M 353.87M 371.74M 320.82M
EBITDA 606.40M 583.65M 672.99M 691.11M 721.59M
Diluted EPS 1.56 1.79 1.69 1.77 1.53
Dividends Per Share 0.43 0.53 0.59 0.63 0.66
Total Assets 2,348.12M 2,511.14M 3,027.54M 3,132.99M 3,606.04M
Total liabilities 737.25M 639.39M 757.22M 737.11M 1,027.65M
Total equity 1,626.41M 1,879.26M 2,263.75M 2,389.20M 2,572.21M
Operating cash flow 348.03M 303.19M 471.34M 403.47M 489.13M

Valuation Measures

Mar 2020
PER46.95
ROA9.47%
ROE12.86%
Operating margin18.04%
Profit margin11.55%

Key executives

  • Chairman, Chief Executive Officer & President: Hisashi Ietsugu
  • Director, CTO & COO-LS Business Unit: Kaoru Asano
  • CFO, Director & Senior Managing Executive Officer: Yukio Nakajima
  • Manager-Informatics: Yasuhiro Takachi
  • Executive Officer: Keiji Fujimoto

Shareholders

  • Baillie Gifford & Co. (5.9%)
  • Kobe Yamabuki Foundation (5.7%)
  • Nakatani Foundation (5.6%)
  • Nakatani Kosan YK (4.9%)
  • IETSUGU KAZUKO (2.9%)
  • WADA TAEKO (2.9%)
  • The Vanguard Group, Inc. (2.5%)
  • IETSUGU FAMILY (2.2%)
  • Nomura Asset Management Co., Ltd. (2.1%)
  • NAKATANI TADAKO (1.9%)

Contact Details

  • Website:http://www.sysmex.co.jp
  • Address: 1-5-1 Wakinohama-Kaigandori, Chuo-Ku, Kobe, 651-0073, Japan
  • Phone: +81.78.265.0500

Related Companies

  • Oxford Gene Technology (Operations) Ltd.
  • Sysmex Medical Electronics (Shanghai) Co., Ltd.
  • Sysmex Wuxi Co. Ltd.
  • Sysmex Inostics, Inc.
  • Sysmex Turkey Diagnostik Sistemleri Ltd. STI
  • Sysmex (Malaysia) Sdn.Bhd.
  • Sysmex Vietnam Co. Ltd.
  • Sysmex Taiwan Co. Ltd.
  • Sysmex Suisse AG
  • Sysmex Slovakia sro
  • Sysmex Shanghai Ltd.
  • Sysmex RUS LLC
  • Sysmex Polska Sp zoo
  • Sysmex Philippines, Inc.
  • Sysmex Hungaria Kft.
  • Sysmex Hong Kong Ltd.
  • Sysmex Espana SL
  • Sysmex do Brasil Industria e Comercio Ltda.
  • Sysmex CZ sro
  • Sysmex Canada, Inc.
  • Sysmex Austria GmbH
  • Sysmex Middle East FZ LLC
  • Sysmex South Africa (Pty) Ltd.
  • Sysmex Inostics GmbH
  • Sysmex Korea Co., Ltd.
  • Katakura Industries Co. Ltd. /Biological Research Center/
  • Sysmex RA Co. Ltd.
  • Sysmex Europe GmbH
  • Sysmex Deutschland GmbH
  • Sysmex TMC Co., Ltd.

Competitors

  • bioMerieux SA
  • Haemonetics Corporation
  • Bio-Techne Corporation
  • Guardant Health, Inc.
  • Autobio Diagnostics Co., Ltd. Class A
  • Epigenomics AG
  • Genomictree, Inc.
  • Biocept, Inc.
Last Updated on 7 Aug, 2020

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends July 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media